METOCLOPRAMIDE INJ TRADE DATA ANALYSIS
Analyze Metoclopramide Inj export import data and locate key markets, reliable suppliers, and active buyers by utilizing Eximpedia's data-centric platform.Whether you're a supplier looking for high-demand markets or a buyer sourcing apples from reliable exporters, Eximpedia’s data-driven approach for making informed trade decisions.
METOCLOPRAMIDE INJ – Overview
Eximpedia analyses Metoclopramide Inj export import records, including data from 83 buyers and 19 suppliers. We provide an intelligence report of Apple that covers trade statistics, shipment values, quantities, exporters & importers, trade destinations, and HS codes.
Metoclopramide Inj Buyers, Suppliers & Shipments
Products Metoclopramide Inj import markets
Gain insights into Product Metoclopramide Inj with data on monthly import values, major importing countries, key ports, leading competitors, and active suppliers.
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004909000 | 0.21 | 10 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049000000 | 0.20 | 12 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004902900 | 0.14 | 3 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049090 | 0.04 | 2 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049099000 | 0.03 | 2 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| INDIA | 0.38 | 20 | 0.00 |
| CHINA | 0.19 | 6 | 0.00 |
| TAIWAN, PROVINCE OF CHINA | 0.03 | 2 | 0.00 |
| KOREA, REPUBLIC OF | 0.03 | 1 | 0.00 |
| HONG KONG | 0.01 | 1 | 0.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 4601, NEW YORK/NEWARK AREA, NEWARK, NJ | 0.00 | 4 | 0.00 |
| GUAYAQUIL MARITIMO | 0.14 | 3 | 0.00 |
| APAPA PORT | 0.15 | 3 | 0.00 |
| MANILA INTERNATIONAL CONTAINER TERMINAL | 0.03 | 2 | 0.00 |
| BOMBAY AIR CARGO | 0.00 | 1 | 0.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| A NWAEZE PHARMACEUTICAL COMPANY LIMITED | 0.06 | 1 |
| CHRIS NELB PHARMACEUTICAL NIGERIA IMITED | 0.09 | 1 |
| COMERCIALIZADORA NUTRI MED NUTRIMEDECUADOR S A | 0.06 | 39 |
| COMERCIALIZADORA NUTRI MED NUTRIMEDECUADOR SA | 0.08 | 27 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|
Discover the Hidden Opportunities in HS Code Metoclopramide Inj—access key decision-makers and detailed reports to save time and succeed.
Metoclopramide Inj Import Market
Explore Product Metoclopramide Inj with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30049099000 | PHARMACEUTICAL PRODUCTS METOCLOPRAMIDE INJ (LIOTHYL) 2ML*10 |  |
|
TAIWAN, PROVINCE OF CHINA | PHILIPPINES | 14 |
| 30049099000 | PHARMACEUTICAL PRODUCTS METOCLOPRAMIDE INJ. (LIOTHYL SOLUTION FOR INJ 10MG/2ML) | |
|
TAIWAN, PROVINCE OF CHINA | PHILIPPINES | 34 |
| 3004909000 | METOCLOPRAMIDE INJECTION 10MG/2ML (PHILOMETRO) | |
|
CHINA | NIGERIA | 0 |
| 3004902900 | METOCLOPRAMIDE INJECTION | |
|
INDIA | EQUADOR | 4554 |
| 3004909000 | METOCLOPRAMIDE INJECTION 10MG/2ML | |
|
CHINA | NIGERIA | 0 |
| 30049099000 | PHARMACEUTICAL PRODUCTS METOCLOPRAMIDE INJ (LIOTHYL) 2ML*10 | |
|
TAIWAN, PROVINCE OF CHINA | PHILIPPINES | 14 |
| 30049099000 | PHARMACEUTICAL PRODUCTS METOCLOPRAMIDE INJ. (LIOTHYL SOLUTION FOR INJ 10MG/2ML) | |
|
TAIWAN, PROVINCE OF CHINA | PHILIPPINES | 34 |
| 291229 | FUROSEMIDE INJECTION USP 20MG PER 2ML FUROSEMINJECTION USP 10MG/2ML METOCLOPRAMIDE INJECTION USP 5MG/ML | |
|
IN, INDIA | USA | 12 |
| 3004909000 | METOCLOPRAMIDE INJECTION BP 10MG/2ML_X000D_47 BOXES X 200_X000D_LI# 2255 PAGE 238_X000D_(PHARMACEUTICAL FINISHED PRODUCT)_X000D_API . _X000D_PHARMAX INDIA PVT.LTD_X000D_9KURLA INDUSTRIES ESTATE.NARAYAM NAGAR.DHATKOPAR(W)_X000D_MUMBAI- INDIA | |
|
INDIA | GHANA | 9500 |
| 3004909000 | METOCLOPRAMIDE INJECTION BP 10MG/2ML _43 BOXES X 200_LI# 2255 PAGE 238_(PHARMACEUTICAL FINISHED PRODUCT) | |
|
INDIA | GHANA | 8600 |
| 310510 | 2062 CARTONS ON 39 PALLETS TORSEMIDE TAB.100+20MG METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 LEVOTHYROXINE SOD TABLETS 0.125 MG 1000 NET WEIGHT: 11.399,712 KG TEMPERATURE TO BE SET TO +22 DEGREES CENTRIGRADE | |
|
BE, BELGIUM | USA | 2062 |
| 293740 | 1973 CARTONS ON 41 PALLETS BUSPIRONE HCL TAB.USP 100+10MG TRIAMCINOLONE ACET.INJ.USP,40MG ML,1ML+1 LIOTHYRONINE SODIUM TBL. USP 25MCGX100 LIOTHYRONINE SODIUM TBL. USP 50MCGX100 METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 TRAZODONE HCL USP TABLETS 100MGX1000 | |
|
BE, BELGIUM | USA | 1973 |
| 291229 | 1658 CARTONS ON 40 PALLETS TORSEMIDE TAB.100+20MG METOCLOPRAMIDE USP TBL.100+10MG TRIAMCINOLONE ACET.INJ.USP,40MG ML,1ML+1 METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 NET WEIGHT: 7.914,136 KG TEMPERATURE TO BE SET TO +22 DEGREES CENTRIGRADE | |
|
BE, BELGIUM | USA | 1658 |
| 310510 | 2210 CARTONS ON 38 PALLETS METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 TRAZODONE HCL USP TABLETS 50MGX100 NET WEIGHT: 11.610,900 KG TEMPERATURE TO BE SET TO +22 DEGREES CENTRIGRADE | |
|
IT, ITALY | USA | 2210 |
| 291229 | 1658 CARTONS ON 40 PALLETS TORSEMIDE TAB.100+20MG METOCLOPRAMIDE USP TBL.100+10MG TRIAMCINOLONE ACET.INJ.USP,40MG ML,1ML+1 METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 NET WEIGHT: 7.914,136 KG TEMPERATURE TO BE SET TO +22 DEGREES CENTRIGRADE | |
|
BE, BELGIUM | USA | 1658 |
| 293740 | 1973 CARTONS ON 41 PALLETS BUSPIRONE HCL TAB.USP 100+10MG TRIAMCINOLONE ACET.INJ.USP,40MG ML,1ML+1 LIOTHYRONINE SODIUM TBL. USP 25MCGX100 LIOTHYRONINE SODIUM TBL. USP 50MCGX100 METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 TRAZODONE HCL USP TABLETS 100MGX1000 | |
|
BE, BELGIUM | USA | 1973 |
| 310510 | 2062 CARTONS ON 39 PALLETS TORSEMIDE TAB.100+20MG METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 LEVOTHYROXINE SOD TABLETS 0.125 MG 1000 NET WEIGHT: 11.399,712 KG TEMPERATURE TO BE SET TO +22 DEGREES CENTRIGRADE | |
|
BE, BELGIUM | USA | 2062 |
| 310510 | 2210 CARTONS ON 38 PALLETS METOCLOPRAMIDE INJECTION USP 10MG 2MLX25 TRAZODONE HCL USP TABLETS 50MGX100 NET WEIGHT: 11.610,900 KG TEMPERATURE TO BE SET TO +22 DEGREES CENTRIGRADE | |
|
IT, ITALY | USA | 2210 |
| 291229 | FUROSEMIDE INJECTION USP 20MG PER 2ML FUROSEMINJECTION USP 10MG/2ML METOCLOPRAMIDE INJECTION USP 5MG/ML | |
|
IN, INDIA | USA | 12 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Products Metoclopramide Inj export markets
Discover Products Metoclopramide Inj with data on monthly export values, major exporting countries, key ports, leading competitors, and active buyers.
TOP EXPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30049035 | 4.89 | 117 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049099 | 1.46 | 86 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049034 | 0.05 | 7 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30045010 | 0.01 | 4 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 29242930 | 0.01 | 1 | 0.00 |
| CARBOXYAMIDE-FUNCTION COMPOUNDS; AMIDE-FUNCTION COMPOUNDS OF CARBONIC ACID | |||
TOP EXPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UNITED STATES | 4.04 | 22 | 0.00 |
| SOUTH AFRICA | 0.77 | 7 | 0.00 |
| ECUADOR | 0.23 | 4 | 0.00 |
| CANADA | 0.19 | 3 | 0.00 |
| IRAQ | 0.13 | 6 | 0.00 |
TOP EXPORT PORTS
| PORTS | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| NHAVA SHEVA SEA | 1.62 | 75 | 0.00 |
| BOMBAY AIR CARGO | 0.06 | 47 | 0.00 |
| SABARMATI ICD | 0.72 | 21 | 0.00 |
| AHMEDABAD AIR CARGO | 2.56 | 19 | 0.00 |
| MUNDRA SEA | 0.65 | 8 | 0.00 |
TOP EXPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| STERIL GENE LIFE SCIENCES PRIVATE LIMITED | 0.16 | 728 |
| MAIVA PHARMA PRIVATE LIMITED | 0.20 | 235 |
| AVET LIFESCIENCES PRIVATE LIMITED | 3.84 | 286 |
| CADILA PHARMACEUTICALS LIMITED | 0.75 | 2441 |
| ACULIFE HEALTHCARE PRIVATE LIMITED | 0.26 | 622 |
TOP EXPORT BUYERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| JAMP PHARMA CORPORATION | 0.16 | 674 |
| AVENACY INC | 0.20 | 6 |
| TOTALCARE PHARMA S A | 0.23 | 31 |
| AUSTELL PHARMACEUTICAL PTY LIMITED | 0.75 | 10 |
| AVET PHARMACEUTICALS INC | 3.84 | 518 |
Access the complete database of 83 buyers and 19 suppliers with a one-time subscription plan.
Metoclopramide Inj Export Market
Analyze HSN Code Metoclopramide Inj with product description, export values, quantities, importer name, country of origin and key import destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30049099 | PHARMACEUTICAL PRODUCTS METOCLOPRAMIDE INJECTION 10MG/2ML AMPOULESBATCH NO. DA 591, MFG DT: DEC-23, EXP DT: N | |
|
INDIA | DOMINICAN REPUBLIC | 43500 |
| 30049099 | PHARMACEUTICAL PRODUCTS METOCLOPRAMIDE INJECTION 10MG/2ML AMPOULES BATCH NO. DA559, MFG DT NOV-23, EXP DT OCT-26 | |
|
INDIA | DOMINICAN REPUBLIC | 181500 |
| 30049099 | PHARMACEUTICAL FORMATION : METOCLOPRAMIDE INJECTION BP , METOCLOPRAMIDE INJECTION BP 10 MG/2ML B.NO.ML24175 | |
|
INDIA | AFGHANISTAN | 50000 |
| 30049099 | PHARMACEUTICAL FORMATION : MAKCLOP ,METOCLOPRAMIDE INJECTION BP AS PER INVOICE. | |
|
INDIA | OMAN | 40800 |
| 30049099 | METOGOOD (METOCLOPRAMIDE INJECTIONBP 5 MG/ML) | |
|
INDIA | KENYA | 10000 |
| 30049035 | METOCLOPRAMIDE INJECTIOIN 10MG/2ML (5MG/ML) | |
|
INDIA | UNITED ARAB EMIRATES | 194800 |
| 30049035 | METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML AMPOULE | |
|
INDIA | IRAQ | 192400 |
| 30049035 | METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML AMPOULE | |
|
INDIA | IRAQ | 192300 |
| 30049035 | METOCLOPRAMIDE INJECTIOIN 10MG/2ML (5MG/ML) | |
|
INDIA | UNITED ARAB EMIRATES | 192000 |
| 30049035 | METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML AMPOULE | |
|
INDIA | IRAQ | 194800 |
| 30049099 | PHARMACEUTICAL GOODS/HARMLESS MEDICINESFOR HUMAN USE-METOSWISS METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML(100,000 AMPS) | |
|
INDIA | TANZANIA, UNITED REPUBLIC OF | 100000 |
| 30049099 | PHARMACEUTICAL GOODS/HARMLESS MEDICINESFOR HUMAN USE-VOMICARE METOCLOPRAMIDE INJ BP 5MG/ML,2ML(100000 AMPS) | |
|
INDIA | LEBANON | 100000 |
| 30049099 | PHARMACEUTICAL GOODS/HARMLESS MEDICINESFOR HUMAN USE-METOSWISS METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML (99400 AMPS) | |
|
INDIA | IRAQ | 99400 |
| 30049034 | METOCLOPRAMIDE INJECTION BP 10MG/2ML(LP-B2-18M.11/2023E.10/2025) | |
|
INDIA | SRI LANKA | 40000 |
| 30049034 | METOCLOPRAMIDE INJECTION BP 10MG IN 2ML(S-B1-9 M.12/2023 E.11/2025)(6000 PACKSX10 AMPS) | |
|
INDIA | SRI LANKA | 60000 |
| 30049034 | METOCLOPRAMIDE INJECTION BP10 MG IN 2ML(BETANORM) BATCH NO:LP-B2-15 TO LP-B2-16, EXP DT 12/2024,05/2025 | |
|
INDIA | SRI LANKA | 60000 |
| 30049034 | METOCLOPRAMIDE INJECTION BP 10MG/2ML(BETANORM) BATCH NO.LP-B2-19 EXP DT 06/2026 | |
|
INDIA | SRI LANKA | 50000 |
| 30049034 | METOCLOPRAMIDE INJECTION BP 10 MG/ 2 ML(BETANORM) BATCH NO.LP-B2-17 EXP.08/2025 | |
|
INDIA | SRI LANKA | 40000 |
| 30049034 | METOCLOPRAMIDE INJECTION BP 10MG IN 2ML(S-B1-9 M.12/2023 E.11/2025)(6000 PACKSX10 AMPS) | |
|
INDIA | SRI LANKA | 60000 |
| 30049034 | METOCLOPRAMIDE INJECTION BP 10MG IN 2ML(S-B1-9 M.12/2023 E.11/2025)(6000 PACKSX10 AMPS) | |
|
INDIA | SRI LANKA | 60000 |
Why should you choose Eximpedia?
Deep-Analysis Report
Get reports on market trends, price, volume, HS Code supply, product details, country of origin, number of buyers & suppliers, and total shipments with Eximpedia's deep analysis reports.
Access Database Across 130+ Countries
Gain statistical and analytical reports, competitors' shipment records, and country-specific data from over 130 countries.
20 types of unique dashboards
Eximpedia offers 20 types of unique dashboards, tailored to meet diverse business needs. From trade insights to buyer analysis, each dashboard delivers actionable data at your fingertips.
Effortless Global Buyer Discovery
Explore international markets with ease! Access over 5 billion records to identify buyers in 130+ countries with just a click.
Supplier Stability Monitor
Leverage historical shipment data and real-time alerts for a complete view of supplier reliability and performance.
Competitor Pricing Strategy Intelligence
Utilise our data-driven platform to uncover competitors’ pricing strategies and track market pricing trends.